Herr, Harry Wallace

Publications

Sort by

Co-Author Network

selected publications

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort^†: Under the Auspices of the EAU-ESMO Guidelines Committees. European urology. 2019 Conference Paper GET IT
Times cited: 117
EDITORIAL COMMENT. Urology. 2019 Comment GET IT
Times cited: 1
Preventable Cancer Deaths Associated with Bladder Preservation for Muscle Invasive Bladder Cancer. Urology. 2019 Editorial Article GET IT
Times cited: 4
Propensity-matched analysis of patient-reported outcomes for neoadjuvant chemotherapy prior to radical cystectomy. World journal of urology. 2019 Academic Article GET IT
Times cited: 5
The Outcome of Post-Chemotherapy Retroperitoneal Lymph Node Dissection in Patients with Metastatic Bladder Cancer in the Retroperitoneum. Bladder cancer (Amsterdam, Netherlands). 2019 Academic Article GET IT
Times cited: 4
Reduced Recurrence of Low-grade Papillary Bladder Tumors Associated With Asymptomatic Bacteriuria. Urology. 2018 Academic Article GET IT
Times cited: 3
Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy. European urology. 2018 Academic Article GET IT
Times cited: 92
Comparison of Postradical Cystectomy Ileus Rates Using GIA-80 Versus GIA-60 Intestinal Stapler Device. Urology. 2018 Academic Article GET IT
Times cited: 5
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018. 2018 GET IT
Times cited: 151
Conservative Management Following Complete Clinical Response to Neoadjuvant Chemotherapy of Muscle Invasive Bladder Cancer: Contemporary Outcomes of a Multi-Institutional Cohort Study. The Journal of urology. 2018 Academic Article GET IT
Times cited: 43
Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes. European urology. 2018 Academic Article GET IT
Times cited: 173
Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Academic Article GET IT
Times cited: 94
Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma. Human pathology. 2018 Academic Article GET IT
Times cited: 25
Importance of wide re-resection in adult spermatic cord sarcomas: Report on oncologic outcomes at a single institution. Journal of surgical oncology. 2018 Academic Article GET IT
Times cited: 5
Urothelial neoplasms in pediatric and young adult patients: A large single-center series. Journal of pediatric surgery. 2017 Academic Article GET IT
Times cited: 16
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. 2017 GET IT
Times cited: 194
Improving the quality of operative reports for transurethral resection of bladder tumor surgery in resident education. The Canadian journal of urology. 2017 Academic Article GET IT
Times cited: 7
Clinical Outcomes of Patients With T1 Nested Variant of Urothelial Carcinoma Compared to Pure Urothelial Carcinoma of the Bladder. Clinical genitourinary cancer. 2017 Academic Article GET IT
Times cited: 17
Is restaging transurethral resection necessary in patients with non-muscle invasive bladder cancer and limited lamina propria invasion?. Urologic oncology. 2017 Academic Article GET IT
Times cited: 13
The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy. European urology focus. 2017 Academic Article GET IT
Times cited: 39
Pursuing Novel Ideas-Confessions of Lost Opportunities!. Urology. 2017 Article GET IT
Single Arm Phase I/II Study of Everolimus and Intravesical Gemcitabine in Patients with Primary or Secondary Carcinoma In Situ of the Bladder who failed Bacillus Calmette Guerin (NCT01259063). Bladder cancer (Amsterdam, Netherlands). 2017 Academic Article GET IT
Times cited: 11
Regionalization of radical cystectomy in the United States. Urologic oncology. 2017 Academic Article GET IT
Times cited: 13
From Galen's Urine to Harvey's Blood. Urology. 2017 Academic Article GET IT
Times cited: 1
Re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61. European urology. 2016 Letter GET IT
Times cited: 2
NCCN Guidelines Insights: Bladder Cancer, Version 2.2016. 2016 GET IT
Times cited: 79
Commentary: Does Asymptomatic Bacteriuria Reduce the Risk of Recurrence of Non-muscle-invasive Bladder Tumors?. Urology. 2016 Academic Article GET IT
Times cited: 6
COUNTERPOINT: Is Immediate Radical Cystectomy Justified When Non-Muscle-Invasive Bladder Cancer First Presents as High-Grade T1 Urothelial Carcinoma on Re-Resection?. Oncology (Williston Park, N.Y.). 2016 Academic Article GET IT
Retraction notice to "Randomized Trial of Narrow-band Versus White-light Cystoscopy for Restaging (Second-look) Transurethral Resection of Bladder Tumors": Eur Urol 67 (2015) 605-608. European urology. 2016 Academic Article GET IT
Times cited: 1
Retraction notice to "Reply from Author re: Peter C. Black. Narrowing the Cystoscopy Gap. Eur Urol 2015;67:609-10: A Better Transurethral Resection-Proved or Not!": Eur Urol 67 (2015) 610-611. European urology. 2016 Academic Article GET IT
Cystoscopy and intravesical bacille Calmette-Guérin therapy in antibiotic-naïve patients with bladder cancer with asymptomatic bacteriuria: An update. Arab journal of urology. 2016 Review GET IT
Times cited: 3
A 10-Item Checklist Improves Reporting of Critical Procedural Elements during Transurethral Resection of Bladder Tumor. The Journal of urology. 2016 Academic Article GET IT
Times cited: 36
Validating a Local Failure Risk Stratification for Use in Prospective Studies of Adjuvant Radiation Therapy for Bladder Cancer. International journal of radiation oncology, biology, physics. 2016 Academic Article GET IT
Times cited: 14
Idiographic quality of life assessment before radical cystectomy. Psycho-oncology. 2015 Academic Article GET IT
Times cited: 7
Re: Herr et al.: BCG-refractory vs. BCG-relapsing non-muscle-invasive bladder cancer: A prospective cohort outcomes study (Urol Oncol 2015; 33: 108.el-108.e4). Urologic oncology. 2015 Letter GET IT
Role of Repeat Resection in Non-Muscle-Invasive Bladder Cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2015 Review GET IT
Times cited: 24
BCG-refractory vs. BCG-relapsing non-muscle-invasive bladder cancer: a prospective cohort outcomes study. Urologic oncology. 2015 Academic Article GET IT
Times cited: 38
A cost-effectiveness analysis of management of low-risk non-muscle-invasive bladder cancer using office-based fulguration. Urology. 2015 Academic Article GET IT
Times cited: 24
Reply: To PMID 25623694. Urology. 2015 Comment GET IT
Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial. European urology. 2014 Academic Article GET IT
Times cited: 434
Multicenter evaluation of the role of UroVysion FISH assay in surveillance of patients with bladder cancer: does FISH positivity anticipate recurrence?. World journal of urology. 2014 Academic Article GET IT
Times cited: 36
Diagnosis and management of urothelial carcinoma in situ of the lower urinary tract: a systematic review. European urology. 2014 Review GET IT
Times cited: 55
Partial Cystectomy after Neoadjuvant Chemotherapy: Memorial Sloan Kettering Cancer Center Contemporary Experience. International scholarly research notices. 2014 Academic Article GET IT
Times cited: 286
Efficacy and safety of MCNA in patients with nonmuscle invasive bladder cancer at high risk for recurrence and progression after failed treatment with bacillus Calmette-Guérin. The Journal of urology. 2014 Academic Article GET IT
Times cited: 66
Robotic radical cystectomy--is the diversion the Achilles' heel?. The Journal of urology. 2014 Academic Article GET IT
Times cited: 21
Risk of fracture after radical cystectomy and urinary diversion for bladder cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Academic Article GET IT
Times cited: 23
Reply from Author re: Peter C. Black. Narrowing the cystoscopy gap. Eur Urol 2015;67:609-10: A better transurethral resection--proved or not!. European urology. 2014 Editorial Article GET IT
Clinical value of transurethral second resection of bladder tumor: systematic review. Urology. 2014 Review GET IT
Times cited: 34
The risk of urinary tract infection after flexible cystoscopy in patients with bladder tumor who did not receive prophylactic antibiotics. The Journal of urology. 2014 Academic Article GET IT
Times cited: 44
Randomized trial of narrow-band versus white-light cystoscopy for restaging (second-look) transurethral resection of bladder tumors. European urology. 2014 Academic Article GET IT
Times cited: 28
Bladder biopsy of normal-appearing mucosa is not helpful in patients with unexplained positive cytology after nonmuscle invasive bladder cancer. The Journal of urology. 2014 Academic Article GET IT
Times cited: 5
Adherence to surveillance guidelines after radical cystectomy: a population-based analysis. Urologic oncology. 2014 Academic Article GET IT
Times cited: 10
Preoperative serum albumin is associated with mortality and complications after radical cystectomy. BJU international. 2014 Academic Article GET IT
Times cited: 72
Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis. The Journal of urology. 2014 Academic Article GET IT
Times cited: 66
Narrow-band imaging evaluation of bladder tumors. Current urology reports. 2014 Review GET IT
Times cited: 10
Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder. The Journal of urology. 2014 Academic Article GET IT
Times cited: 59
Innovation vs experimentation - who decides?: Re: Sundaram V, Vemana G, Bhayani SB. Institutional Review Board approval and innovation in urology: current practice and safety issues. BJU Int 2014; 113: 343-7. BJU international. 2014 Editorial Article GET IT
Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review. European urology. 2014 Review GET IT
Times cited: 233
Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy. BJU international. 2014 Academic Article GET IT
Times cited: 28
Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710. Cancer. 2014 Academic Article GET IT
Times cited: 57
Reply to Donald L. Lamm and Nilay M. Gandhi's letter to the editor re: Behfar Ehdaie, Richard Sylvester, Harry W. Herr. Maintenance bacillus Calmette-Guérin treatment of non-muscle-invasive bladder cancer: a critical evaluation of the evidence. Eur Urol 2013;64:579-85. European urology. 2013 Letter GET IT
Times cited: 1
Should antibiotics be given prior to outpatient cystoscopy? A plea to urologists to practice antibiotic stewardship. European urology. 2013 Academic Article GET IT
Times cited: 50
The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin. The Journal of urology. 2013 Academic Article GET IT
Times cited: 125
Risk factors and predictors of severity score and complications of pediatric hemorrhagic cystitis. The Journal of urology. 2013 Academic Article GET IT
Times cited: 32
Office-based management of nonmuscle invasive bladder cancer. The Urologic clinics of North America. 2013 Review GET IT
Times cited: 9
Maintenance bacillus Calmette-Guérin treatment of non-muscle-invasive bladder cancer: a critical evaluation of the evidence. European urology. 2013 Review GET IT
Times cited: 64
Upper tract imaging surveillance is not effective in diagnosing upper tract recurrence in patients followed for nonmuscle invasive bladder cancer. The Journal of urology. 2013 Academic Article GET IT
Times cited: 32
Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guérin treatment failure. The Journal of urology. 2013 Academic Article GET IT
Times cited: 35
Penile cancer: Clinical Practice Guidelines in Oncology. 2013 GET IT
Times cited: 137
Radical cystectomy and orthotopic urinary reconstruction in patients with bladder cancer after renal transplantation: clinical outcomes and description of technique. Transplantation proceedings. 2013 Academic Article GET IT
Times cited: 8
Bladder cancer. 2013 GET IT
Times cited: 294
Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance. Urologic oncology. 2013 Academic Article GET IT
Times cited: 2
Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer. BJU international. 2013 Academic Article GET IT
Times cited: 71
Intravesical bacille Calmette-Guérin (BCG) in immunologically compromised patients with bladder cancer. BJU international. 2013 Academic Article GET IT
Times cited: 27
Management of bladder cancer after renal transplantation. Urology. 2013 Academic Article GET IT
Times cited: 24
Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection. BJU international. 2012 Academic Article GET IT
Times cited: 22
Adjuvant intravesical bacillus calmette-guérin therapy and survival among elderly patients with non-muscle-invasive bladder cancer. Journal of oncology practice. 2012 Academic Article GET IT
Times cited: 35
Preoperative accuracy of diagnostic evaluation of the urachal mass. The Journal of urology. 2012 Academic Article GET IT
Times cited: 30
Urinary diversion practice patterns among certifying American urologists. The Journal of urology. 2012 Academic Article GET IT
Times cited: 13
Intravesical bacille Calmette-Guérin eradicates bacteriuria in antibiotic-naïve bladder cancer patients. European urology. 2012 Academic Article GET IT
Times cited: 10
Outpatient urological procedures in antibiotic-naive patients with bladder cancer with asymptomatic bacteriuria. BJU international. 2012 Academic Article GET IT
Times cited: 22
Epidemiology and risk factors of urothelial bladder cancer. European urology. 2012 Review GET IT
Times cited: 1404
Lymph node density for patient counselling about prognosis and for designing clinical trials of adjuvant therapies after radical cystectomy. BJU international. 2012 Academic Article GET IT
Times cited: 23
Follow-up after surgical treatment of bladder cancer: a critical analysis of the literature. European urology. 2012 Review GET IT
Times cited: 91
Editorial comment. Urology. 2012 Editorial Article GET IT
Times cited: 2
Editorial comment. Urology. 2012 Comment GET IT
Intravesical bacillus Calmette-Guérin outcomes in patients with bladder cancer and asymptomatic bacteriuria. The Journal of urology. 2011 Academic Article GET IT
Times cited: 18
Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma. The Journal of urology. 2011 Academic Article GET IT
Times cited: 34
Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy. The Journal of urology. 2011 Academic Article GET IT
Times cited: 54
Screening urine analysis before bacille Calmette-Guérin instillation does not reduce the rate of infectious complications. BJU international. 2011 Academic Article GET IT
Times cited: 6
Repeated white light transurethral resection of the bladder in nonmuscle-invasive urothelial bladder cancers: systematic review and meta-analysis. Journal of endourology. 2011 Review GET IT
Times cited: 33
Percivall Pott, the environment and cancer. BJU international. 2011 Academic Article GET IT
Times cited: 5
Is repeat transurethral resection needed for minimally invasive T1 urothelial cancer? Pro. The Journal of urology. 2011 Academic Article GET IT
Times cited: 4
Ethnic differences in bladder cancer survival. Urology. 2011 Academic Article GET IT
Times cited: 83
Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer. BJU international. 2011 Academic Article GET IT
Times cited: 23
The role of laparoscopic and robotic cystectomy in the management of muscle-invasive bladder cancer with special emphasis on cancer control and complications. European urology. 2011 Review GET IT
Times cited: 126
Is 'second-look' (re-staging) transurethral resection of bladder tumours a new standard of care?. Arab journal of urology. 2011 Review GET IT
Times cited: 1
Kuhn's paradigms: are those closest to treating bladder cancer the last to appreciate the paradigm shift?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Editorial Article GET IT
Times cited: 27
A plea for a uniform surveillance schedule after radical cystectomy. The Journal of urology. 2011 Academic Article GET IT
Times cited: 11
Intravesical bacille Calmette-Guerin in patients with asymptomatic bacteriuria. JAMA. 2011 Academic Article GET IT
Times cited: 10
Bacillus Calmette-Guérin without maintenance therapy for high-risk non-muscle-invasive bladder cancer. European urology. 2011 Academic Article GET IT
Times cited: 60
Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy. BJU international. 2011 Academic Article GET IT
Times cited: 12
Role of re-resection in non-muscle-invasive bladder cancer. TheScientificWorldJournal. 2011 Review GET IT
Times cited: 36
Words of Wisdom. Re: use of radical cystectomy for patients with invasive bladder cancer. European urology. 2011 Comment GET IT
Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy. European urology. 2011 Review GET IT
Times cited: 44
Narrow band imaging cystoscopy. Urologic oncology. 2011 Article GET IT
Times cited: 13
Impact of smoking on outcomes after intravesical bacillus Calmette-Guérin therapy for urothelial carcinoma not invading muscle of the bladder. BJU international. 2010 Academic Article GET IT
Times cited: 31
Bladder cancer in cystoscopically normal-appearing mucosa: a case of mistaken identity?. BJU international. 2010 Academic Article GET IT
Times cited: 8
Variability of treatment selection among surgeons for patients with cT1 urothelial carcinoma. BJU international. 2010 Academic Article GET IT
Times cited: 13
Editorial comment. Urology. 2010 Editorial Article GET IT
Reduced bladder tumour recurrence rate associated with narrow-band imaging surveillance cystoscopy. BJU international. 2010 Academic Article GET IT
Times cited: 68
Clinical outcomes of primary bladder carcinoma in situ in a contemporary series. The Journal of urology. 2010 Academic Article GET IT
Times cited: 46
Clinical outcome of primary versus secondary bladder carcinoma in situ. The Journal of urology. 2010 Academic Article GET IT
Times cited: 34
Radical cystectomy in octogenarians--does morbidity outweigh the potential survival benefits?. The Journal of urology. 2010 Academic Article GET IT
Times cited: 114
Re: Derya Tilki, Oliver Reich, Pierre I. Karakiewicz, et al. Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome. Eur Urol 2010;58:112-7. European urology. 2010 Letter GET IT
Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer. The Journal of urology. 2010 Academic Article GET IT
Times cited: 22
Words of wisdom. Re: Rethinking screening for breast cancer and prostate cancer. European urology. 2010 Comment GET IT
Accuracy of the extent of bladder cancer nodal metastases found at pelvic lymphadenectomy at the time of cystectomy: relation to primary tumor stage. Urologia internationalis. 2010 Academic Article GET IT
Times cited: 2
Editorial comment. Urology. 2010 Editorial Article GET IT
Editorial comment. Urology. 2010 Editorial Article GET IT
Legends in urology. The Canadian journal of urology. 2010 Editorial Article GET IT
Narrow-band imaging cystoscopy to evaluate bladder tumours--individual surgeon variability. BJU international. 2009 Academic Article GET IT
Times cited: 41
The effect of gender on response to bacillus Calmette-Guérin therapy for patients with non-muscle-invasive urothelial carcinoma of the bladder. BJU international. 2009 Academic Article GET IT
Times cited: 48
Editorial comment. Urology. 2009 Editorial Article GET IT
High-risk, high-grade (T1G3) bladder cancer: models versus reality. Cancer. 2009 Editorial Article GET IT
Times cited: 2
Extent of pelvic lymph node dissection during radical cystectomy: where and why!. European urology. 2009 Editorial Article GET IT
Times cited: 13
Editorial comment. Urology. 2009 Editorial Article GET IT
Times cited: 1
Narrow-band imaging cystoscopy to evaluate the response to bacille Calmette-Guérin therapy: preliminary results. BJU international. 2009 Academic Article GET IT
Times cited: 23
Fibrin clot inhibitor medication and efficacy of bacillus Calmette-Guerin for bladder urothelial cancer. The Journal of urology. 2009 Academic Article GET IT
Times cited: 18
Editorial comment. Pelvic lymphadenectomy during robot-assisted radical prostatectomy: assessing nodal yield, perioperative outcomes, and complications. Urology. 2009 Editorial Article GET IT
Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer. European urology. 2009 Academic Article GET IT
Times cited: 107
Editorial comment. Urology. 2009 Comment GET IT
Should all patients receive single chemotherapeutic agent instillation after bladder tumour resection?. BJU international. 2009 Review GET IT
Times cited: 28
'Cello scrotum' hoax. BJU international. 2009 Letter GET IT
Editorial comment. Patients with low-grade papillary bladder tumors could be monitored safely, deferring therapy unless the recurrent tumors increased in size or number. Urology. 2009 Comment GET IT
Civiale, stones and statistics: the dawn of evidence-based medicine. BJU international. 2009 Academic Article GET IT
Times cited: 7
Complications following radical cystectomy for bladder cancer in the elderly. European urology. 2009 Review GET IT
Times cited: 216
Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation. The American journal of surgical pathology. 2009 Academic Article GET IT
Times cited: 187
Reflex UroVysion testing in suspicious urine cytology cases. Cancer. 2009 Academic Article GET IT
Times cited: 41
Goat glands rejuvenated. BJU international. 2009 Letter GET IT
Perioperative intravesical therapy: effective treatment, unfulfilled promises. European urology. 2009 Editorial Article GET IT
Times cited: 3
Bladder cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2009 Conference Paper GET IT
Times cited: 60
Optimizing outcomes at every stage of bladder cancer: do we practice it?. Urologic oncology. 2009 Review GET IT
Times cited: 14
Is metastasectomy for urothelial carcinoma worthwhile?. European urology. 2008 Editorial Article GET IT
Times cited: 12
Neoadjuvant chemotherapy: a new treatment paradigm for muscle-invasive bladder cancer. European urology. 2008 Editorial Article GET IT
Times cited: 9
A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience. Cancer. 2008 Academic Article GET IT
Times cited: 219
Quality control in transurethral resection of bladder tumours. BJU international. 2008 Academic Article GET IT
Times cited: 168
Surgical management of renal tumors: a historical perspective. The Urologic clinics of North America. 2008 Academic Article GET IT
Times cited: 25
Point: effect of radiation-associated second malignancies on prostate cancer survival. Urology. 2008 Academic Article GET IT
Times cited: 10
A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences. BJU international. 2008 Academic Article GET IT
Times cited: 149
Editorial comment on: External beam radiation therapy followed by interstitial radiotherapy with iridium-192 for solitary bladder tumours: results of 111 treated patients. European urology. 2008 Editorial Article GET IT
Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy. European urology. 2008 Editorial Article GET IT
Times cited: 7
Contemporary imaging of patients with a renal mass: does size on computed tomography equal pathological size?. BJU international. 2008 Academic Article GET IT
Times cited: 43
'I will not cut . . . ': the oath that defined urology. BJU international. 2008 Academic Article GET IT
Times cited: 4
Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. European urology. 2008 Academic Article GET IT
Times cited: 1043
Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience. European urology. 2008 Academic Article GET IT
Times cited: 192
Is maintenance Bacillus Calmette-Guérin really necessary?. European urology. 2008 Editorial Article GET IT
Times cited: 50
Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer. 2008 Academic Article GET IT
Times cited: 241
Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. The Journal of urology. 2008 Academic Article GET IT
Times cited: 236
'Crushing the stone': a brief history of lithotripsy, the first minimally invasive surgery. BJU international. 2008 Academic Article GET IT
Times cited: 13
Editorial comment on: robotic-assisted laparoscopic radical cystectomy with extracorporeal urinary diversion: initial experience. European urology. 2008 Editorial Article GET IT
Times cited: 5
'Cutting for the stone': the ancient art of lithotomy. BJU international. 2008 Academic Article GET IT
Times cited: 22
Rebuttal from author re: Axel Heidenreich. Muscle-invasive urothelial carcinoma of the bladder: neoadjuvant chemotherapy enables organ preserving therapy in carefully selected patients. Eur Urol 2008;54:21-23. European urology. 2008 Editorial Article GET IT
Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF. Journal of immunotherapy (Hagerstown, Md. : 1997). 2008 Academic Article GET IT
Times cited: 56
Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 151
Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer. European urology. 2007 Academic Article GET IT
Times cited: 70
History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story. The Journal of urology. 2007 Academic Article GET IT
Times cited: 247
Is radical radiotherapy effective in patients with pT1G3 NXM0 bladder cancer?. Nature clinical practice. Urology. 2007 Comment GET IT
Times cited: 1
Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance. The Journal of urology. 2007 Academic Article GET IT
Times cited: 73
Low risk bladder tumors--less is more!. The Journal of urology. 2007 Editorial Article GET IT
Times cited: 5
Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. The Journal of urology. 2007 Academic Article GET IT
Times cited: 197
Re: Francesco Montorsi. A plea for integrating laparoscopy and robotic surgery in everyday urology: the rules of the game. Eur urol 2007;52:307-9. European urology. 2007 Letter GET IT
Management of low grade papillary bladder tumors. The Journal of urology. 2007 Academic Article GET IT
Times cited: 103
Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy. European urology. 2007 Academic Article GET IT
Times cited: 89
Age and outcome of superficial bladder cancer treated with bacille Calmette-Guérin therapy. Urology. 2007 Academic Article GET IT
Times cited: 74
Urachal carcinoma: contemporary surgical outcomes. The Journal of urology. 2007 Academic Article GET IT
Times cited: 123
Hunter Holmes McGuire and the coffee pot spout procedure. The Journal of urology. 2007 Academic Article GET IT
Times cited: 1
The concept of lymph node density--is it ready for clinical practice?. The Journal of urology. 2007 Review GET IT
Times cited: 41
Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer. The Journal of urology. 2007 Academic Article GET IT
Times cited: 132
Use of urinary biomarkers for bladder cancer surveillance: patient perspectives. The Journal of urology. 2007 Academic Article GET IT
Times cited: 66
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma. Proceedings of the National Academy of Sciences of the United States of America. 2007 Academic Article GET IT
Times cited: 411
Does difluoromethylornithine prevent recurrence in low-risk superficial bladder cancer?. Nature clinical practice. Urology. 2007 Comment GET IT
Times cited: 1
Defining optimal therapy for muscle invasive bladder cancer. The Journal of urology. 2007 Review GET IT
Times cited: 180
Ignorance is bliss: the Listerian revolution and education of American surgeons. The Journal of urology. 2007 Academic Article GET IT
Times cited: 8
Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract. Urology. 2007 Academic Article GET IT
Times cited: 60
Should we abandon the FISH test?. European urology. 2007 Editorial Article GET IT
Times cited: 25
Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?. The Journal of urology. 2007 Academic Article GET IT
Times cited: 123
Life of a contract surgeon. The journal of Civil War medicine : official quarterly publication of the Society of Civil War Surgeons, Inc. 2007 Academic Article GET IT
Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder. BJU international. 2006 Academic Article GET IT
Times cited: 41
Bladder cancer. Clinical guidelines in oncology. 2006 GET IT
Times cited: 25
Natural history of positive urinary cytology after radical cystectomy. The Journal of urology. 2006 Academic Article GET IT
Times cited: 20
Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer. Cancer. 2006 Academic Article GET IT
Times cited: 64
The enlarged prostate: a brief history of its surgical treatment. BJU international. 2006 Review GET IT
Times cited: 22
Max Nitze, the cystoscope and urology. The Journal of urology. 2006 Academic Article GET IT
Times cited: 39
Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment. Annals of oncology : official journal of the European Society for Medical Oncology. 2006 Academic Article GET IT
Times cited: 32
Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients. The Journal of urology. 2006 Academic Article GET IT
Times cited: 47
Henry Wade (1876-1955): an early 20th century cancer researcher and pioneer urologist. BJU international. 2006 Academic Article GET IT
NMP22 and surveillance for recurrent bladder cancer. JAMA. 2006 Letter GET IT
Times cited: 1
Formulas calculating creatinine clearance are inadequate for determining eligibility for Cisplatin-based chemotherapy in bladder cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 63
Complications after radical cystectomy: analysis of population-based data. Urology. 2006 Academic Article GET IT
Times cited: 211
Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 151
Association between urinary cytology and pathology for nontransitional cell malignancies of the urinary tract. The Journal of urology. 2006 Academic Article GET IT
Times cited: 6
Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer. BJU international. 2006 Academic Article GET IT
Times cited: 46
A re-staging transurethral resection predicts early progression of superficial bladder cancer. BJU international. 2006 Academic Article GET IT
Times cited: 96
Early history of endoscopic treatment of bladder tumors from Grunfeld's polypenkneipe to the Stern-McCarthy resectoscope. Journal of endourology. 2006 Academic Article GET IT
Times cited: 17
Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. The Journal of urology. 2005 Academic Article GET IT
Times cited: 152
Urine cytology after flexible cystoscopy. BJU international. 2005 Academic Article GET IT
Times cited: 3
Quality of care: partial cystectomy for bladder cancer--a case of inappropriate use?. The Journal of urology. 2005 Academic Article GET IT
Times cited: 36
Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population. Urology. 2005 Academic Article GET IT
Times cited: 84
Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer?. The Journal of urology. 2005 Academic Article GET IT
Times cited: 56
Surgical factors in the treatment of superficial and invasive bladder cancer. The Urologic clinics of North America. 2005 Review GET IT
Times cited: 35
Is less radical cystectomy better, and how can we be sure?. The Journal of urology. 2005 Editorial Article GET IT
Legacy of Edwin Beer: fulguration of papillary bladder tumors. The Journal of urology. 2005 Academic Article GET IT
Times cited: 17
Urethral injuries in the Civil War. The Journal of urology. 2005 Academic Article GET IT
Times cited: 9
A history of partial nephrectomy for renal tumors. The Journal of urology. 2005 Academic Article GET IT
Times cited: 67
Bladder cancer. Clinical practice guidelines in oncology. 2005 GET IT
Times cited: 12
Franklin, Lavoisier, and Mesmer: origin of the controlled clinical trial. Urologic oncology. 2005 Academic Article GET IT
Times cited: 13
The integration of chemotherapy and surgery for bladder cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2005 Review GET IT
Times cited: 9
Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. The Journal of urology. 2004 Academic Article GET IT
Times cited: 84
Urological injuries in the Civil War. The Journal of urology. 2004 Academic Article GET IT
Times cited: 14
Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping. The Journal of urology. 2004 Academic Article GET IT
Times cited: 176
Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection. The Journal of urology. 2004 Academic Article GET IT
Times cited: 114
Standardization of radical cystectomy: time to count and be counted. BJU international. 2004 Academic Article GET IT
Times cited: 15
Surgical factors influence bladder cancer outcomes: a cooperative group report. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Academic Article GET IT
Times cited: 498
Pathologic evaluation of radical cystectomy specimens: a cooperative group report. Cancer. 2004 Academic Article GET IT
Times cited: 34
Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report. The Journal of urology. 2004 Academic Article GET IT
Times cited: 251
Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5 cm. The Journal of urology. 2004 Academic Article GET IT
Times cited: 72
Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study. The Journal of urology. 2004 Academic Article GET IT
Times cited: 83
Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer. Cancer immunity. 2003 Academic Article GET IT
Times cited: 67
Fluid intake and the risk of tumor recurrence in patients with superficial bladder cancer. The Journal of urology. 2003 Academic Article GET IT
Times cited: 15
Presacral cystic schwannoma in a man. 2003 GET IT
Times cited: 24
Surgical factors in bladder cancer: more (nodes) + more (pathology) = less (mortality). BJU international. 2003 Academic Article GET IT
Times cited: 36
Defining bacillus Calmette-Guerin refractory superficial bladder tumors. The Journal of urology. 2003 Academic Article GET IT
Times cited: 149
Adherence to surveillance among patients with superficial bladder cancer. Journal of the National Cancer Institute. 2003 Academic Article GET IT
Times cited: 115
Superiority of ratio based lymph node staging for bladder cancer. The Journal of urology. 2003 Academic Article GET IT
Times cited: 268
Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy. The Journal of urology. 2003 Academic Article GET IT
Times cited: 53
Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology. 2003 Academic Article GET IT
Times cited: 159
Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence. The Journal of urology. 2003 Academic Article GET IT
Times cited: 103
Reply to editorial -- Technologies and traditional skills, Laurence H. Klotz, Can J Urol 2002;9(4):1572-1573. The Canadian journal of urology. 2002 Letter GET IT
Impact of a second transurethral resection on the staging of T1 bladder cancer. Urology. 2002 Academic Article GET IT
Times cited: 100
Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder. The Journal of urology. 2002 Academic Article GET IT
Times cited: 71
Pathologic evaluation of radical cystectomy specimens. Cancer. 2002 Academic Article GET IT
Times cited: 10
Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 149
Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 39
Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. The Journal of urology. 2002 Academic Article GET IT
Times cited: 521
A comparison of hospital-based charges following partial and radical nephrectomy. Urologic oncology. 2002 Academic Article GET IT
Times cited: 13
Immediate versus delayed outpatient flexible cystoscopy: final report of a randomized study. The Canadian journal of urology. 2001 Academic Article GET IT
Times cited: 12
Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. The Journal of urology. 2001 Academic Article GET IT
Times cited: 228
Does cystoscopy correlate with the histology of recurrent papillary tumours of the bladder?. BJU international. 2001 Academic Article GET IT
Times cited: 49
Results of high dose rate brachytherapy, anterior pelvic exenteration and external beam radiotherapy for carcinoma of the female urethra. The Journal of urology. 2001 Academic Article GET IT
Times cited: 23
Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?. The Journal of urology. 2001 Academic Article GET IT
Times cited: 332
Genetic alterations in tp53 in recurrent urothelial cancer: a longitudinal study. Clinical cancer research : an official journal of the American Association for Cancer Research. 2001 Academic Article GET IT
Times cited: 34
Radiographic versus pathologic size of renal tumors: implications for partial nephrectomy. Urology. 2001 Academic Article GET IT
Times cited: 36
Outpatient flexible cystoscopy in men: a randomized study of patient tolerance. The Journal of urology. 2001 Academic Article GET IT
Times cited: 41
The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer. The Journal of urology. 2001 Academic Article GET IT
Times cited: 73
Cystectomy for bladder cancer: a contemporary series. The Journal of urology. 2001 Academic Article GET IT
Times cited: 393
Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 90
Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance. The Journal of urology. 2001 Academic Article GET IT
Times cited: 63
Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer. The Journal of urology. 2001 Academic Article GET IT
Times cited: 140
Editorial comment. Urology. 2001 Comment GET IT
Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. The Journal of urology. 2001 Academic Article GET IT
Times cited: 163
Transurethral resection of muscle-invasive bladder cancer: 10-year outcome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 196
Upper-tract tumors after an initial diagnosis of bladder cancer: argument for long-term surveillance. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 91
Phase II trial of pyrazoloacridine as second-line therapy for patients with unresectable or metastatic transitional cell carcinoma. Investigational new drugs. 2000 Academic Article GET IT
Times cited: 19
Timing of cystectomy for superficial bladder tumors. Urologic oncology. 2000 Academic Article GET IT
Times cited: 11
Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy. The Journal of urology. 2000 Academic Article GET IT
Times cited: 224
Carcinoid tumor of the kidney. The use of somatostatin receptor scintigraphy in diagnosis and management. Urologic oncology. 2000 Academic Article GET IT
Times cited: 29
Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: final report of a phase II trial evaluating two dosing schedules. Cancer. 2000 Academic Article GET IT
Times cited: 111
Current use and questions concerning intravesical bladder cancer group for superficial bladder cancer. The Urologic clinics of North America. 2000 Review GET IT
Times cited: 64
Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2000 Academic Article GET IT
Times cited: 64
Carcinoma in situ in the testis. Scandinavian journal of urology and nephrology. Supplementum. 2000 Review GET IT
Times cited: 153
Evaluation of drug delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancer. Cancer investigation. 2000 Academic Article GET IT
Times cited: 9
Radiographic vs surgical size of renal tumours after partial nephrectomy. BJU international. 2000 Academic Article GET IT
Times cited: 31
Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome. The Journal of urology. 2000 Academic Article GET IT
Times cited: 183
Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer. 1999 Academic Article GET IT
Times cited: 149
The natural history of a T1 bladder cancer: life-long tumour diathesis. 1999 GET IT
Times cited: 14
Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 Academic Article GET IT
Times cited: 612
Progression of T1 bladder tumors: better staging or better biology?. Cancer. 1999 Editorial Article GET IT
Times cited: 9
Is transurethral biopsy of the bladder necessary after 3 months to evaluate response to bacillus Calmette-Guerin therapy?. The Journal of urology. 1999 Academic Article GET IT
Times cited: 36
Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 Academic Article GET IT
Times cited: 149
The value of a second transurethral resection in evaluating patients with bladder tumors. The Journal of urology. 1999 Academic Article GET IT
Times cited: 424
Male urethral carcinoma: analysis of treatment outcome. Urology. 1999 Academic Article GET IT
Times cited: 116
Prostatic tumor relapse in patients with superficial bladder tumors: 15-year outcome. The Journal of urology. 1999 Academic Article GET IT
Times cited: 40
Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma. Cancer. 1999 Academic Article GET IT
Times cited: 9
Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. The Journal of urology. 1999 Academic Article GET IT
Times cited: 173
Can p53 help select patients with invasive bladder cancer for bladder preservation?. The Journal of urology. 1999 Academic Article GET IT
Times cited: 46
Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney: 10-year followup. The Journal of urology. 1999 Academic Article GET IT
Times cited: 310
The impact of primary stage on survival in patients with lymph node positive bladder cancer. The Journal of urology. 1999 Academic Article GET IT
Times cited: 100
Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategy. British journal of urology. 1998 Academic Article GET IT
Times cited: 81
Tumour progression and survival in patients with T1G3 bladder tumours. British journal of urology. 1998 Letter GET IT
Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
Times cited: 83
NCCN urothelial cancer practice guidelines. National Comprehensive Cancer Network. 1998 GET IT
Times cited: 48
Evaluation of new resectoscope loop for transurethral resection of bladder tumors. The Journal of urology. 1998 Academic Article GET IT
Times cited: 14
Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
Times cited: 170
Role of surgery in management of germ cell tumor. Seminars in oncology. 1998 Review GET IT
Times cited: 55
Clinical stage I testis cancer: long-term outcome of patients on surveillance. The Journal of urology. 1998 Academic Article GET IT
Times cited: 134
Extravesical tumor relapse in patients with superficial bladder tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
Times cited: 84
Localized squamous cell carcinoma of the bladder causing hypercalcemia and inhibition of PTH secretion. 1998 GET IT
Times cited: 10
Paternity in men with stage I testis tumors on surveillance. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
Times cited: 36
Prognostic risk factors in low stage testicular germ cell tumors: unanswered questions regarding clinically useful prognosticators for extratesticular disease. Cancer. 1998 Letter GET IT
Times cited: 1
Updated concepts and treatment of carcinoma in situ. Urologic oncology. 1998 Academic Article GET IT
Times cited: 41
Radical cystectomy in the octogenarian. The Journal of urology. 1997 Review GET IT
Times cited: 119
Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome. British journal of urology. 1997 Academic Article GET IT
Times cited: 157
Adjuvant and neoadjuvant chemotherapy for urothelial carcinoma. Surgical oncology clinics of North America. 1997 Review GET IT
Times cited: 1
Does necrosis on frozen-section analysis of a mass after chemotherapy justify a limited retroperitoneal resection in patients with advanced testis cancer?. British journal of urology. 1997 Academic Article GET IT
Times cited: 45
Is biopsy of the contralateral testis necessary in patients with germ cell tumors?. The Journal of urology. 1997 Review GET IT
Times cited: 65
Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 1997 Academic Article GET IT
Times cited: 64
Ureteral carcinoma in situ at radical cystectomy: does the margin matter?. The Journal of urology. 1997 Academic Article GET IT
Times cited: 53
CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria. AJR. American journal of roentgenology. 1997 Academic Article GET IT
Times cited: 126
High-risk superficial bladder cancer: transurethral resection alone in selected patients with T1 tumor. Seminars in urologic oncology. 1997 Review GET IT
Times cited: 26
The treated natural history of high risk superficial bladder cancer: 15-year outcome. The Journal of urology. 1997 Review GET IT
Times cited: 457
Summary of effect of intravesical bacillus Calmette-Guerin (BCG) on carcinoma in situ of the bladder (by Harry W. Herr, MD, Carl M. Pinsky, MD, Willet F. Whitmore, Jr, MD, Herbert F. Oettgen, MD, and Myron R. Melamed, MD). 1983. Seminars in urologic oncology. 1997 Academic Article GET IT
Times cited: 5
Does current chemotherapy improve survival of patients with invasive bladder cancer?. Urology. 1997 Academic Article GET IT
Times cited: 8
Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II study. British journal of urology. 1997 Academic Article GET IT
Times cited: 37
Surgery for a post-chemotherapy residual mass in seminoma. The Journal of urology. 1997 Review GET IT
Times cited: 137
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results. Urology. 1997 Academic Article GET IT
Times cited: 80
Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients. World journal of urology. 1997 Review GET IT
Times cited: 108
Quality of life in prostate cancer patients. CA: a cancer journal for clinicians. 1997 Academic Article GET IT
Times cited: 71
Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guérin therapy: correlation to clinical outcome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 122
The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1996 Academic Article GET IT
Times cited: 142
Upper tract tumors in patients with primary bladder cancer followed for 15 years. The Journal of urology. 1996 Academic Article GET IT
Times cited: 91
Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancer. The Journal of urology. 1996 Academic Article GET IT
Times cited: 52
Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 81
Routine CT scan in cystectomy patients: does it change management?. Urology. 1996 Academic Article GET IT
Times cited: 40
Defining new standards for adjuvant therapy of testis cancer: a reply. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Letter GET IT
Times cited: 2
Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 152
Renal cell carcinoma in childhood and adolescence: a retrospective survey for prognostic factors in 22 cases. Journal of pediatric surgery. 1996 Academic Article GET IT
Times cited: 51
Selecting clinical research projects for the urologic oncologist. Urologic oncology. 1996 Academic Article GET IT
Uncertainty and outcome of invasive bladder tumors. Urologic oncology. 1996 Academic Article GET IT
Times cited: 26
Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995 Academic Article GET IT
Times cited: 62
BCG immunotherapy for transitional-cell carcinoma in situ of the bladder. Oncology (Williston Park, N.Y.). 1995 Review GET IT
Times cited: 44
Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program. American journal of epidemiology. 1995 Academic Article GET IT
Times cited: 94
Current methods of assessing and treating carcinoma in situ of the bladder with or without involvement of the prostatic urethra. International journal of urology : official journal of the Japanese Urological Association. 1995 Review GET IT
Times cited: 26
Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995 Academic Article GET IT
Times cited: 269
Neoadjuvant and adjuvant chemotherapy in advanced disease--what are the effects on survival and prognosis?. International journal of urology : official journal of the Japanese Urological Association. 1995 Review GET IT
Times cited: 33
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995 Academic Article GET IT
Times cited: 239
Patterns of care for carcinoma of the prostate gland: results of a national survey of 1984 and 1990. Journal of the American College of Surgeons. 1995 Academic Article GET IT
Times cited: 79
Carcinoma in situ of the bladder. The Journal of urology. 1995 Review GET IT
Times cited: 169
Experience with neoadjuvant diethylstilboestrol and radical prostatectomy in patients with locally advanced prostate cancer. British journal of urology. 1994 Academic Article GET IT
Times cited: 35
Partial nephrectomy for incidental renal cell carcinoma. British journal of urology. 1994 Academic Article GET IT
Times cited: 51
Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors. Cancer. 1994 Academic Article GET IT
Times cited: 93
Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder. The Journal of urology. 1994 Academic Article GET IT
Times cited: 188
Positive urinary cytology following a complete response to intravesical bacillus Calmette-Guerin therapy: pattern of recurrence. The Journal of urology. 1994 Academic Article GET IT
Times cited: 24
Uncertainty, stage and outcome of invasive bladder cancer. The Journal of urology. 1994 Editorial Article GET IT
Times cited: 23
Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994 Academic Article GET IT
Times cited: 141
The management of patients with nonseminomatous germ cell tumors of the testis with serologic disease only after orchiectomy. The Journal of urology. 1994 Academic Article GET IT
Times cited: 69
The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The Memorial Sloan-Kettering Cancer Center experience. Cancer. 1994 Academic Article GET IT
Times cited: 83
Quality of life of patients with prostate cancer and their spouses. The value of a data base in clinical care. Cancer. 1994 Academic Article GET IT
Times cited: 287
Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994 Academic Article GET IT
Times cited: 67
Quality of life of incontinent men after radical prostatectomy. The Journal of urology. 1994 Academic Article GET IT
Times cited: 153
Bladder cancer: advances in biology and treatment. Critical reviews in oncology/hematology. 1994 Review GET IT
Times cited: 8
Urachal carcinoma: the case for extended partial cystectomy. The Journal of urology. 1994 Academic Article GET IT
Times cited: 70
Partial nephrectomy for renal cell carcinoma with a normal opposite kidney. Cancer. 1994 Academic Article GET IT
Times cited: 45
Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 1994 Academic Article GET IT
Times cited: 49
The management of clinically unconfirmed positive urinary cytology. The Journal of urology. 1993 Review GET IT
Times cited: 57
Association of primary germ cell tumor of the testis and renal cell carcinoma. 1993 GET IT
Times cited: 9
P53 nuclear overexpression and disease progression in ta-bladder carcinoma. International journal of oncology. 1993 Academic Article GET IT
Times cited: 40
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1993 Academic Article GET IT
Times cited: 306
The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. 1993 GET IT
Times cited: 247
Untreated hypernephroma of thirty-three years. 1993 GET IT
Times cited: 2
A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy. Cancer. 1993 Academic Article GET IT
Times cited: 119
Fertility and testis cancer. The Urologic clinics of North America. 1993 Review GET IT
Times cited: 39
Management of teratoma. The Urologic clinics of North America. 1993 Review GET IT
Times cited: 25
Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. Journal of the National Cancer Institute. 1993 Academic Article GET IT
Times cited: 501
A proposed simplified staging system of invasive bladder tumors. Urologia internationalis. 1993 Academic Article GET IT
Times cited: 17
Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors. The Journal of urology. 1992 Academic Article GET IT
Times cited: 83
Staging invasive bladder tumors. Journal of surgical oncology. 1992 Review GET IT
Times cited: 36
Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers. Cancer. 1992 Academic Article GET IT
Times cited: 91
Transurethral resection in regionally advanced bladder cancer. The Urologic clinics of North America. 1992 Review GET IT
Times cited: 24
Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy. The Journal of urology. 1992 Review GET IT
Times cited: 145
Adult urological sarcoma. The Journal of urology. 1992 Academic Article GET IT
Times cited: 191
Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup. The Journal of urology. 1992 Academic Article GET IT
Times cited: 183
Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors. Seminars in oncology. 1992 Review GET IT
Times cited: 60
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. The Journal of urology. 1992 Academic Article GET IT
Times cited: 671
Management of local bacillus Calmette-Guerin failures in superficial bladder cancer. The Journal of urology. 1992 Academic Article GET IT
Times cited: 30
The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary Group. The Journal of urology. 1992 Academic Article GET IT
Times cited: 126
Intravesical therapy. Hematology/oncology clinics of North America. 1992 Review GET IT
Times cited: 5
High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated. Cancer. 1992 Academic Article GET IT
Times cited: 114
Intervention strategies for chemoprevention of bladder cancer. Journal of cellular biochemistry. Supplement. 1992 Academic Article GET IT
Times cited: 1
Intravesical BCG: current results, natural history and implications for urothelial cancer prevention. Journal of cellular biochemistry. Supplement. 1992 Review GET IT
Times cited: 47
Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer. Cancer treatment and research. 1992 Academic Article GET IT
Times cited: 10
[The role of radiotherapy in locally limited prostate cancer]. Der Urologe. Ausg. A. 1991 Review GET IT
Times cited: 3
Preoperative prostate-specific antigen in predicting pathologic stage and grade after radical prostatectomy. Urology. 1991 Academic Article GET IT
Times cited: 10
Transurethral resection and intravesical therapy of superficial bladder tumors. The Urologic clinics of North America. 1991 Academic Article GET IT
Times cited: 45
Perirenal lipoma versus renal cell carcinoma. 1991 GET IT
Times cited: 2
Renal cell metastases versus liver hemangioma. 1991 GET IT
Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989). Cancer. 1991 Academic Article GET IT
Times cited: 142
Local BCG failures in superficial bladder cancer. A multivariate analysis of risk factors influencing survival. European urology. 1991 Academic Article GET IT
Times cited: 18
Patient selection for retroperitoneal lymph node dissection after chemotherapy for nonseminomatous germ cell tumors. European urology. 1991 Academic Article GET IT
Times cited: 14
Progression of stage T1 bladder tumors after intravesical bacillus Calmette-Guerin. The Journal of urology. 1991 Academic Article GET IT
Times cited: 69
pT1 bladder cancer. European urology. 1991 Review GET IT
Times cited: 13
The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors. Cancer. 1990 Academic Article GET IT
Times cited: 112
Outpatient flexible cystoscopy and fulguration of recurrent superficial bladder tumors. The Journal of urology. 1990 Academic Article GET IT
Times cited: 55
Neoadjuvant chemotherapy in invasive bladder cancer: the evolving role of surgery. The Journal of urology. 1990 Review GET IT
Times cited: 47
The T1 bladder tumor. Seminars in urology. 1990 Review GET IT
Times cited: 79
Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1990 Academic Article GET IT
Times cited: 253
Prognostic factors in bladder and bladder-prostate rhabdomyosarcoma. Journal of pediatric surgery. 1990 Academic Article GET IT
Times cited: 14
Surgery of invasive bladder cancer: is pathologic staging necessary?. Seminars in oncology. 1990 Review GET IT
Times cited: 18
Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience. Seminars in urology. 1990 Academic Article GET IT
Times cited: 7
Surgical treatment of brain metastases from renal cell carcinoma. Urology. 1990 Academic Article GET IT
Times cited: 57
Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors. Cancer. 1990 Academic Article GET IT
Times cited: 31
Pelvic sarcoma causing gynecomastia. 1990 GET IT
Times cited: 3
Suprapubic approach for bilateral orchiectomy and placement of testicular prostheses. The Journal of urology. 1990 Academic Article GET IT
Times cited: 1
The response of patients with superficial bladder cancer to a second course of intravesical bacillus Calmette-Guerin. The Journal of urology. 1990 Academic Article GET IT
Times cited: 51
Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation. The Journal of urology. 1990 Academic Article GET IT
Times cited: 73
M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservation. Progress in clinical and biological research. 1990 Academic Article GET IT
Times cited: 21
The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group. Progress in clinical and biological research. 1990 Academic Article GET IT
Times cited: 19
The role of surgery in initial staging and follow up. Progress in clinical and biological research. 1990 Review GET IT
Times cited: 4
Treatment of locoregional germ cell tumor. Progress in clinical and biological research. 1990 Review GET IT
Times cited: 1
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer. 1989 Academic Article GET IT
Times cited: 643
Conservative treatment of superficial transitional cell carcinoma of prostatic urethra with intravesical BCG. Urology. 1989 Academic Article GET IT
Times cited: 20
Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen. British journal of urology. 1989 Academic Article GET IT
Times cited: 102
Mortality in pediatric paratesticular rhabdomyosarcoma: a multivariate analysis. The Journal of urology. 1989 Academic Article GET IT
Times cited: 34
The evolving role of surgery in the management of renal cell carcinoma. Seminars in urology. 1989 Review GET IT
Times cited: 3
Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus Calmette-Guerin. The Journal of urology. 1989 Academic Article GET IT
Times cited: 24
Intravesical bacillus Calmette-Guerin therapy for in situ transitional cell carcinoma involving the prostatic urethra. The Journal of urology. 1989 Academic Article GET IT
Times cited: 61
BCG therapy of superficial bladder tumors. Progress in clinical and biological research. 1989 Review GET IT
Times cited: 1
Is chemotherapy a new form of radical treatment in infiltrating tumor localized to the bladder?. Progress in clinical and biological research. 1989 Academic Article GET IT
Times cited: 6
Neoadjuvant chemotherapy for invasive bladder cancer. Seminars in surgical oncology. 1989 Review GET IT
Times cited: 9
Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression. The Journal of urology. 1989 Academic Article GET IT
Times cited: 225
When is a cystectomy necessary in carcinoma in situ?. Progress in clinical and biological research. 1989 Academic Article GET IT
Times cited: 5
Intravesical thiotepa versus mitomycin C in patients with Ta, T1 and TIS transitional cell carcinoma of the bladder: a phase III prospective randomized study. The Journal of urology. 1988 Academic Article GET IT
Times cited: 40
Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1988 Academic Article GET IT
Times cited: 228
Anticarcinoma activity of rhodamine 123 against a murine renal adenocarcinoma. Cancer research. 1988 Academic Article GET IT
Times cited: 26
Advanced seminoma: the role of chemotherapy and adjunctive surgery. Annals of internal medicine. 1988 Academic Article GET IT
Times cited: 79
Bladder cancer: pelvic lymphadenectomy revisited. Journal of surgical oncology. 1988 Academic Article GET IT
Times cited: 11
M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. The Journal of urology. 1988 Academic Article GET IT
Times cited: 442
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion. The Journal of urology. 1988 Academic Article GET IT
Times cited: 186
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors. The Journal of urology. 1988 Academic Article GET IT
Times cited: 40
Chemotherapeutic management of invasive bladder carcinoma. European urology. 1988 Academic Article GET IT
Times cited: 2
Chemotherapy and cystectomy in patients with bladder carcinoma. European urology. 1988 Academic Article GET IT
M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urothelium. Progress in clinical and biological research. 1988 Academic Article GET IT
Times cited: 2
Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy. Progress in clinical and biological research. 1988 Review GET IT
An overview of intravesical therapy for superficial bladder tumors. The Journal of urology. 1987 Review GET IT
Times cited: 170
Effects of intermittent diethylstilbestrol diphosphate administration on the R3327 rat prostatic carcinoma. Cancer research. 1987 Academic Article GET IT
Times cited: 36
Conservative management of muscle-infiltrating bladder cancer: prospective experience. The Journal of urology. 1987 Academic Article GET IT
Times cited: 157
Monitoring endoscopic treatment of superficial bladder carcinoma by postoperative urinary cytology. The Journal of urology. 1987 Academic Article GET IT
Times cited: 18
Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by postoperative urinary cytology. The Journal of urology. 1987 Academic Article GET IT
Times cited: 8
The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma. Cancer. 1987 Academic Article GET IT
Times cited: 182
Quality of life measurement in testicular cancer patients. Cancer. 1987 Academic Article GET IT
Times cited: 4
The practical use of tumor marker determination in bladder washing specimens. Assessing the urothelium of patients with superficial bladder cancer. Cancer. 1987 Academic Article GET IT
Times cited: 11
Re: Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder. The Journal of urology. 1987 Letter GET IT
Times cited: 1
Strategies for the management of recurrent and advanced urologic cancers. Quality of life. Cancer. 1987 Academic Article GET IT
Times cited: 14
Toxicity of intravesical BCG and its management in patients with superficial bladder tumors. Cancer. 1987 Academic Article GET IT
Times cited: 86
Ureteral carcinoma in situ after successful intravesical therapy for superficial bladder tumors: incidence, possible pathogenesis and management. The Journal of urology. 1987 Academic Article GET IT
Times cited: 64
Fertility status of patients with clinical stage I testis tumors on a surveillance protocol. The Journal of urology. 1987 Academic Article GET IT
Times cited: 26
Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1987 Academic Article GET IT
Times cited: 119
Testicular failure in patients with extragonadal germ cell tumors. Cancer. 1987 Academic Article GET IT
Times cited: 20
The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinoma. Cancer. 1987 Academic Article GET IT
Times cited: 87
Residual mass after chemotherapy for seminoma: changing concepts of management. 1987 GET IT
Times cited: 23
Intravesical therapy. A critical review. The Urologic clinics of North America. 1987 Academic Article GET IT
Times cited: 33
Penile cancer: relation of extent of nodal metastasis to survival. The Journal of urology. 1987 Academic Article GET IT
Times cited: 216
A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1987 Academic Article GET IT
Times cited: 203
Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1987 Academic Article GET IT
Times cited: 58
Endocrine and exocrine profiles of men with testicular tumors before orchiectomy. The Journal of urology. 1987 Academic Article GET IT
Times cited: 76
Interstitial irradiation using I-125 seeds. Progress in clinical and biological research. 1987 Academic Article GET IT
Times cited: 11
Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by serial flow cytometry. 1986 GET IT
Times cited: 35
Intermittent endocrine therapy for advanced prostate cancer. Cancer. 1986 Academic Article GET IT
Times cited: 216
Phase I trial of alpha-difluoromethyl ornithine (DFMO) and methylglyoxal bis (guanylhydrazone) (MGBG) in patients with advanced prostatic cancer. Urology. 1986 Academic Article GET IT
Times cited: 17
VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1986 Academic Article GET IT
Times cited: 166
Flow cytometry in urologic oncology. The Urologic clinics of North America. 1986 Review GET IT
Times cited: 6
Hodgkin's disease of the prostate: a detailed case report. 1986 GET IT
Times cited: 9
Selection of testicular tumor patients for omission of retroperitoneal lymph node dissection. The Journal of urology. 1986 Academic Article GET IT
Times cited: 13
Sequential excision of residual thoracic and retroperitoneal masses after chemotherapy for stage III germ cell tumors. Cancer. 1986 Academic Article GET IT
Times cited: 61
Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder. The Journal of urology. 1986 Academic Article GET IT
Times cited: 160
Clinical follow-up. Progress in clinical and biological research. 1986 Academic Article GET IT
Experimental models of bladder cancer: a critical review. Progress in clinical and biological research. 1986 Review GET IT
Times cited: 16
Surgical techniques in the management of patients with superficial bladder cancer. Progress in clinical and biological research. 1986 Academic Article GET IT
Times cited: 5
Epidermoid cysts of the testis: role of conservative surgery. 1985 GET IT
Times cited: 24
Consideration for treatment of upper urinary tract tumors with topical therapy. Urology. 1985 Academic Article GET IT
Times cited: 5
Effect of intravesical Bacillus Calmette-Guérin on detection of a urothelial differentiation antigen in exfoliated cells of carcinoma in situ of the human urinary bladder. Cancer research. 1985 Academic Article GET IT
Times cited: 15
Durable response of a carcinoma in situ of the renal pelvis to topical bacillus Calmette-Guerin. 1985 GET IT
Times cited: 67
Monitoring intravesical bacillus Calmette-Guerin treatment of bladder carcinoma with flow cytometry. The Journal of urology. 1985 Academic Article GET IT
Times cited: 29
Case profile: Crossed fused ectopia misdiagnosed as retroperitoneal tumor. 1985 GET IT
Endoscopic diagnosis and treatment of upper-tract urothelial tumors. A preliminary report. 1985 GET IT
Times cited: 134
Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. The Journal of urology. 1985 Academic Article GET IT
Times cited: 558
Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors. The American journal of medicine. 1985 Academic Article GET IT
Times cited: 40
VAB-6 as initial treatment of patients with advanced seminoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1985 Academic Article GET IT
Times cited: 43
Experience with intravesical bacillus Calmette-Guèrin therapy of superficial bladder tumors. Urology. 1985 Academic Article GET IT
Times cited: 102
Interstitial radiation: short-term palliation or curative therapy?. Urology. 1985 Academic Article GET IT
Times cited: 28
Partial nephrectomy for a renal oncocytoma associated with tuberous sclerosis. 1985 GET IT
Times cited: 27
Preoperative irradiation with and without chemotherapy as adjunct to radical cystectomy. Urology. 1985 Academic Article GET IT
Times cited: 28
Intravesical administration of bacillus Calmette-Guérin in patients with recurrent superficial carcinoma of the urinary bladder: report of a prospective, randomized trial. Cancer treatment reports. 1985 Academic Article GET IT
Times cited: 72
Effects of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) on the growth of experimental renal adenocarcinoma in mice. Cancer research. 1984 Academic Article GET IT
Times cited: 27
Estrogen, progesterone, and androgen-binding sites in renal cell carcinoma. Observations obtained in Phase II trial of flutamide. Cancer. 1984 Academic Article GET IT
Times cited: 20
Treatment of genitourinary rhabdomyosarcoma in children. The Journal of urology. 1984 Academic Article GET IT
Times cited: 41
VP-16-213 and cisplatin in the treatment of patients with refractory germ cell tumors. American journal of clinical oncology. 1984 Academic Article GET IT
Times cited: 22
Orchiectomy alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1984 Academic Article GET IT
Times cited: 59
Major surgery and scleromyxedema. The New England journal of medicine. 1984 Letter GET IT
Times cited: 8
Potentiation of methylglyoxal-bis-guanylhydrazone by alpha-difluoromethylornithine in rat prostate cancer. Cancer. 1984 Academic Article GET IT
Times cited: 26
Inguinal lymph node metastases from germ cell testicular tumors. The Journal of urology. 1984 Academic Article GET IT
Times cited: 24
Antigrowth effect of polyamine biosynthesis inhibitors on the Dunning R 3327-G prostatic tumor. The Prostate. 1984 Academic Article GET IT
Times cited: 13
Immunotherapy of bladder tumors. Uremia investigation. 1984 Academic Article GET IT
Times cited: 1
Planned preoperative cisplatin and radiation therapy for locally advanced bladder cancer. Cancer. 1983 Academic Article GET IT
Times cited: 27
Renal cell carcinoma extending into inferior vena cava. The Journal of urology. 1983 Academic Article GET IT
Times cited: 40
Interstitial irradiation for localized prostate cancer. Seminars in urology. 1983 Review GET IT
Times cited: 4
Fibrosarcoma associated with intensive chemotherapy for advanced germ cell testicular tumor. 1983 GET IT
Times cited: 7
Bladder carcinosarcoma: histologic variation in metastatic lesions. 1983 GET IT
Times cited: 16
Effect of intravesical Bacillus Calmette-Guerin (BCG) on carcinoma in situ of the bladder. Cancer. 1983 Academic Article GET IT
Times cited: 100
Inferior pubic rami resection with en bloc radical excision for invasive proximal urethral carcinoma. Cancer. 1983 Academic Article GET IT
Times cited: 28
Presumptive downstaging from preoperative irradiation for bladder cancer as determined by flow cytometry: preliminary report. International journal of radiation oncology, biology, physics. 1983 Academic Article GET IT
Times cited: 18
Carcinoma in situ of the bladder. Seminars in urology. 1983 Academic Article GET IT
Times cited: 25
Association of depressed mixed lymphocyte reactivity with the development of bladder carcinoma in patients with papillomas. Cancer. 1983 Academic Article GET IT
Times cited: 4
Panniculectomy in conjunction with radical cystectomy in the obese patient. Surgery, gynecology & obstetrics. 1983 Academic Article GET IT
Times cited: 6
The patient, disease status, and treatment options for prostate cancer: stages B1 and B2. The Prostate. 1983 Academic Article GET IT
Times cited: 3
VAB-6 combination chemotherapy in resected stage II-B testis cancer. Cancer. 1983 Academic Article GET IT
Times cited: 11
Adjuvant vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum chemotherapy regimen with and without maintenance in patients with resected stage IIB testis cancer. The Journal of urology. 1982 Academic Article GET IT
Times cited: 16
An evaluation of automated flow cytometry (FCM) in detection of carcinoma in situ of the urinary bladder. Cancer. 1982 Academic Article GET IT
Times cited: 41
Detection and follow-up of carcinoma of the urinary bladder by flow cytometry. Cancer. 1982 Academic Article GET IT
Times cited: 103
Flow cytometry followup of patients with low stage bladder tumors. The Journal of urology. 1982 Academic Article GET IT
Times cited: 25
HLA antigens in patients with germ cell cancers of the testis. Cancer research. 1982 Academic Article GET IT
Times cited: 33
Flow cytometry of normal and nonneoplastic diseases of the bladder: an estimate of the false positive rate. The Journal of urology. 1982 Academic Article GET IT
Times cited: 32
Orbital metastases from prostatic carcinoma. 1982 GET IT
Times cited: 8
Characterization of bladder papilloma by two-parameter DNA-RNA flow cytometry. Cancer research. 1982 Academic Article GET IT
Times cited: 20
Correlation of histochemical and biochemical analyses of androgen binding in prostatic cancer: relation to therapeutic response. Cancer. 1982 Academic Article GET IT
Times cited: 35
Cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy versus chloroethyl-cyclohexy-nitrosourea in the treatment of metastatic prostatic cancer. The Journal of urology. 1982 Academic Article GET IT
Times cited: 13
Preoperative irradiation and cystectomy for bladder cancer. Cancer. 1982 Academic Article GET IT
Times cited: 48
Henoch-Schönlein purpura associated with cancer of prostate. 1982 GET IT
Times cited: 43
Effect of estrogen on the mixed lymphocyte reaction in normal individuals and prostatic cancer patients. The Prostate. 1982 Academic Article GET IT
Times cited: 1
Effects of estrogen administration on serum testosterone in Copenhagen rats. The Prostate. 1982 Academic Article GET IT
Times cited: 7
Significance of prostatic biopsies after radiation therapy for carcinoma of the prostate. The Prostate. 1982 Academic Article GET IT
Times cited: 34
Radiation-induced sarcoma following radiotherapy for testicular tumor. 1981 GET IT
Times cited: 21
Adherent suppressor cells in the blood of patients with bladder cancer. The Journal of urology. 1981 Academic Article GET IT
Times cited: 8
Conservative management of renal adenoma v. adenocarcinoma. 1981 GET IT
Times cited: 15
VAB-6 combination chemotherapy in disseminated cancer of the testis. Annals of internal medicine. 1981 Academic Article GET IT
Times cited: 83
Combined chemotherapy and surgery in treatment of advanced germ-cell tumors. Cancer. 1981 Academic Article GET IT
Times cited: 80
Automated flow cytometry to monitor intravesical BCG therapy of superficial bladder cancer. 1981 GET IT
Times cited: 21
Androgen stimulated chemotherapy in the Dunning R-3327 prostatic adenocarcinoma. Urological research. 1981 Academic Article GET IT
Times cited: 13
Mercury-induced necrosis of murine renal cell carcinoma. Journal of surgical oncology. 1981 Academic Article GET IT
Times cited: 3
Iodine-125 implantation in the management of localized prostatic carcinoma. The Urologic clinics of North America. 1980 Academic Article GET IT
Times cited: 6
Spontaneous regression of pulmonary metastases from transitional cell carcinoma. 1980 GET IT
Times cited: 7
Cis-diamminedichloride platinum II in the treatment of advanced bladder cancer. The Journal of urology. 1980 Academic Article GET IT
Times cited: 54
Effect of irradiation on the immunocompetence of peripheral blood and regional lymph node lymphocytes in bladder cancer. The Journal of surgical research. 1980 Academic Article GET IT
Suppressor cells in immunodepressed bladder and prostate cancer patients. The Journal of urology. 1980 Academic Article GET IT
Times cited: 23
Ganglioneuroma arising in accessory adrenal gland. 1980 GET IT
Times cited: 15
Urethral stricture disease: experience with patch graft urethroplasty. Military medicine. 1980 Academic Article GET IT
Times cited: 3
Peripheral neuropathy associated with cis-dichlorodiammineplatinum (II) treatment. Cancer. 1979 Academic Article GET IT
Times cited: 67
A new caliper: uses in surgery. American journal of surgery. 1979 Academic Article GET IT
Hemosiderosis of urinary bladder. 1979 GET IT
Times cited: 6
Complications of pelvic lymphadenectomy and retropubic prostatic 125I implantation. Urology. 1979 Academic Article GET IT
Times cited: 25
Idiopathic retroperitonial fibrosis misinterpreted as lymphoma by computed tomography. 1979 GET IT
Times cited: 14
Sexual potency retained with 125I implantation. Geriatrics. 1979 Article GET IT
Cleft glans penis. The Journal of urology. 1979 Letter GET IT
Malignancy in uremia: dialysis versus transplantation. The Journal of urology. 1979 Academic Article GET IT
Times cited: 40
Preservation of sexual potency in prostatic cancer patients after pelvic lymphadenectomy and retropubic 125I implantation. The Journal of urology. 1979 Academic Article GET IT
Times cited: 14
Evaluation of postirradiated prostate biopsy for prostatic carcinoma. Surgical forum. 1979 Academic Article GET IT
Times cited: 3
Preservation of sexual potency in prostatic cancer patients after 125I implantation. Journal of the American Geriatrics Society. 1979 Academic Article GET IT
Times cited: 5
Suppressor cells in the pelvic lymph nodes regional to bladder cancer. Journal of surgical oncology. 1979 Academic Article GET IT
Times cited: 11
Function of cryopreserved human effector cells in antibody-dependent, cell-mediated cytotoxicity. National Cancer Institute monograph. 1978 Academic Article GET IT
Times cited: 1
Immunocompetence of patients with transitional cell carcinoma as measured by dinitrochlorobenzene skin tests and in vitro lymphocyte function. National Cancer Institute monograph. 1978 Academic Article GET IT
Times cited: 2
Mixed leukocyte culture reactivity of lymph node cells regional to transitional cell carcinoma of the bladder. National Cancer Institute monograph. 1978 Academic Article GET IT
Times cited: 1
Poly I:C immunotherapy in patients with papillomas or superficial carcinomas of the bladder. National Cancer Institute monograph. 1978 Academic Article GET IT
Times cited: 11
Cryptorchidism and testicular neoplasia. 1978 GET IT
Times cited: 8
Use of a caliper to determine dimensions of the volume to be implanted with 125iodine in the treatment of prostatic carcinoma. The Journal of urology. 1978 Academic Article GET IT
Times cited: 1
Immune reactivity of lymph nodes regional to prostatic cancer. The Journal of surgical research. 1978 Academic Article GET IT
Times cited: 1
Nonspecific suppressor cells in peripheral blood of patients with urologic cancers. Surgical forum. 1978 Academic Article GET IT
Times cited: 1
Rectal invasion by benign prostatic hyperplasia. 1977 GET IT
Times cited: 1
Immunologic reactivity of lymph nodes regional to prostatic cancer: preliminary observations. Journal of surgical oncology. 1977 Academic Article GET IT
Times cited: 2
Suppressor cell activity in lymph nodes regional to bladder carcinoma. Surgical forum. 1977 Academic Article GET IT
Times cited: 5
Decreased ability of blood leukocytes from patients with tumors of the urinary bladder to act as stimulator cells in mixed leukocyte culture. Cancer research. 1976 Academic Article GET IT
Times cited: 22
Cryopreservation of human effector cells active in antibody-dependent cell-mediated cytotoxicity. Transplantation. 1976 Academic Article GET IT
Times cited: 7
Prognostic significance of regional lymph node histology in cancer of the bladder. The Journal of urology. 1976 Academic Article GET IT
Times cited: 22
Immunobiology of human bladder cancer. The Journal of urology. 1976 Review GET IT
Times cited: 10
Intermittent catheterization in neurogenic bladder dysfunction. The Journal of urology. 1975 Academic Article GET IT
Times cited: 29
Letter: "Immunostaging" patients with malignant disease. Urology. 1975 Academic Article GET IT
Times cited: 2
Pseudocyst of pancreas simulating a renal neoplasm. 1975 GET IT
Times cited: 9
External sphincterotomy in traumatic and non-traumatic neurogenic bladder dysfunction. The Journal of urology. 1975 Academic Article GET IT
Times cited: 6
Recent advances in the immunobiology of human bladder cancer. Clinical bulletin. 1975 Review GET IT
Times cited: 1
Bedside sphincterometry. Urology. 1974 Academic Article GET IT
Times cited: 4
Lipogranulomatosis of external genitalia. Urology. 1974 Academic Article GET IT
Times cited: 18
Hydronephrosis and hydroureter major problem in patients with spinal cord injury. Urology. 1973 Academic Article GET IT
Times cited: 1
Management of inguinal lymph nodes in patients with testicular tumors following orchiopexy, inguinal or scrotal operations. The Journal of urology. 1973 Academic Article GET IT
Times cited: 28
Primary or pseudohyperparathyroidism?. Urology. 1973 Academic Article GET IT
Times cited: 1
Use of prophylactic antibiotics in the high-risk patient undergoing prostatectomy: effect on morbidity. The Journal of urology. 1973 Academic Article GET IT
Times cited: 11
Unsuspected primary cortical renal cell carcinoma presenting as a metastatic subepithelial pelvic filling defect. The Journal of urology. 1973 Academic Article GET IT
Complete vertical cleft of the glans penis. The Journal of urology. 1972 Academic Article GET IT
Times cited: 1

more ...

less ...

Background

education and training

M.D., University of California, Irvine, School of Medicine 1969
A.B., University of California, Davis 1965

Contact

full name

Harry Wallace Herr

VIVO Weill Cornell Medical College

Harry Wallace Herr Professor of Urology

Publications

selected publications

Background

education and training

Contact

full name